Multi-Manager Framework: Greenwald + Dalio + Soros + Druckenmiller + Laffont + Ackman + Cohen/Griffin
Generated: 2026-07-20 19:56:31 · EDGAR + yfinance
ANET is 1127% above EPV, pure growth/narrative bet. Grade A quality. At this premium, you need everything to go right. Position size should reflect speculation, not conviction.
Stage 4 reflexivity intact, momentum 30% with earnings accelerating. R/R of 0.3:1 needs better entry. Above 200MA, Druckenmiller baseline met. Wait for pullback to improve asymmetry.
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| AAPL ✓ | Benchmark: Apple, $3T market cap proxy for br | $4.8T | 37.2x | N/A | 12.5x | 47.7x | 33.9x | +34% | +3% | 0.7x |
| MSFT ✓ | Benchmark: Microsoft, diversified tech; cloud | $3.0T | 28.3x | N/A | 14.1x | 47.7x | 20.8x | +50% | +14% | 0.4x |
| JNJ ✓ | Benchmark: J&J, diversified healthcare; defen | $600B | 23.5x | N/A | 7.7x | 34.6x | 19.4x | +33% | +5% | 1.5x |
| PG ✓ | Benchmark: Procter & Gamble, consumer staples | N/A | 1.7x | N/A | 0.5x | 2.5x | 21.2x | +26% | +3% | 1.2x |
| JPM ✓ | Benchmark: JPMorgan, financials baseline; eco | N/A | N/A | N/A | 8.7x | N/A | 13.8x | N/A | +11% | N/A |
| Peer Median | N/A | 25.9x | N/A | 8.7x | 41.1x | 20.8x | +33% | N/A | 0.9x | |
| Subject Company | N/A | 89.0x | N/A | 36.1x | 119.1x | 37.8x | +41% | N/A | -0.8x | |
| Base EBIT (Operating Income) TTM | $2.3B |
| Line 5: D&A Adj. (Over-depreciation add-back) | +$50M |
| Line 7: Marketing Growth Add-Back (7yr brand life, historical) | +$113M |
| Adjusted EBIT | $2.5B |
| × (1 − Tax Rate) (17.4% actual ETR) | $2.0B |
| Sustainable NOPAT ÷ WACC (13.3%) | $15.3B |
|
Santos/Greenwald Enhancements
ROIC 19.6% (Franchise)Smoothed Margin 37.9%Brand Asset $1.5BD&A Method: Rev Growth Proxy
| |
| 1 | Base EBIT (Operating Income) | $2.3B | From income statement |
| 2 | D&A Adjustment (Greenwald Line 5) | +$50M | Over/underdepreciation vs maintenance CapEx |
| 3 | Marketing Growth Add-Back (Line 7) | +$113M | Marketing $395M − Brand amort $282M (7yr life, historical) |
| ℹ | SBC (already in EBIT) | −$302M | 5.2% of rev, real cost, no add-back |
| 4 | = Adjusted EBIT | $2.5B | |
| 5 | x (1 - Tax Rate) | 17.4% actual ETR | |
| = | Sustainable NOPAT | $2.0B | Net Operating Profit After Tax |
| / | WACC (13.3%) | Weighted average cost of capital | |
| = | EPV Operating | $15.3B | Enterprise value on no-growth basis |
| + | Cash | +$2.0B | |
| - | Total Debt | -$0 | |
| = | EPV of Equity | $17.3B | |
| / | Shares Outstanding | 1256M | |
| = | EPV Per Share | $13.75 | vs. Market Price $168.81 |
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| AAPL ✓ | Benchmark: Apple, $3T market cap proxy for br | $4.8T | 37.2x | N/A | 12.5x | 47.7x | 33.9x | +34% | +3% | 0.7x |
| MSFT ✓ | Benchmark: Microsoft, diversified tech; cloud | $3.0T | 28.3x | N/A | 14.1x | 47.7x | 20.8x | +50% | +14% | 0.4x |
| JNJ ✓ | Benchmark: J&J, diversified healthcare; defen | $600B | 23.5x | N/A | 7.7x | 34.6x | 19.4x | +33% | +5% | 1.5x |
| PG ✓ | Benchmark: Procter & Gamble, consumer staples | N/A | 1.7x | N/A | 0.5x | 2.5x | 21.2x | +26% | +3% | 1.2x |
| JPM ✓ | Benchmark: JPMorgan, financials baseline; eco | N/A | N/A | N/A | 8.7x | N/A | 13.8x | N/A | +11% | N/A |
| Peer Median | N/A | 25.9x | N/A | 8.7x | 41.1x | 20.8x | +33% | N/A | 0.9x | |
| Subject Company | N/A | 89.0x | N/A | 36.1x | 119.1x | 37.8x | +41% | N/A | -0.8x | |
| Asset | Book | Haircut | Liquidation |
|---|---|---|---|
| Cash | $2.0B | 100% | $2.0B |
| Receivables | $6.6B | 85% | $5.6B |
| Inventory | $6.6B | 60% | $4.0B |
| PP&E | $203.1M | 50% | $101.5M |
| Other | $3.3B | 25% | $828.8M |
| Goodwill | $416.1M | 0% | N/A |
| Intangibles | $288.8M | 0% | N/A |